1613 related articles for article (PubMed ID: 28687377)
1. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
2. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
[TBL] [Abstract][Full Text] [Related]
3. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
[TBL] [Abstract][Full Text] [Related]
4. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Palmer JD; Klamer BG; Ballman KV; Brown PD; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
JAMA Oncol; 2022 Dec; 8(12):1809-1815. PubMed ID: 36264568
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
Trifiletti DM; Ballman KV; Brown PD; Anderson SK; Carrero XW; Cerhan JH; Whitton AC; Greenspoon J; Parney IF; Laack NN; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):255-260. PubMed ID: 31654784
[TBL] [Abstract][Full Text] [Related]
6. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
7. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
11. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
[TBL] [Abstract][Full Text] [Related]
12. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
13. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
14. Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study.
Raman S; Mou B; Hsu F; Valev B; Cheung A; Vallières I; Ma R; McKenzie M; Beaton L; Rackley T; Gondara L; Nichol A
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):442-451. PubMed ID: 32085923
[TBL] [Abstract][Full Text] [Related]
15. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
16. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
17. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
18. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
[TBL] [Abstract][Full Text] [Related]
20. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
